First time the FDA has cleared an AI-driven device which has been specifically designed for use with breast cancer surgery.

Independent investigators from the University of Pisa presented new data at the 2026 European Congress of Radiology (ECR) -- Ultrasound follow-up documented predictable scaffold bioresorption and ...

Independent investigators from the University of Pisa presented new data at the 2026 European Congress of Radiology (ECR) Ultrasound follow-up ...

Eventually, every doctor becomes a patient. For many physicians, experiencing serious illness and treatment is humbling, eye-opening, and, in the end, transformative. Dr. Patient is a Medscape series ...

NEWTON, Mass., Dec. 18, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced a new collaboration with ...

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer tumors to kill them — is emerging as a new option. The FDA recently granted ...

GREENVILLE, S.C. (WSPA) – October is Breast Cancer Awareness Month. For women facing a breast cancer diagnosis, one of the biggest decisions is often choosing what kind of surgery to have. As part of ...

24-month Phase I follow-up data show positive outcomes are maintained High levels of investigator and patient satisfaction, excellent safety profile Ongoing registrational trial will yield top-line ...

The MarketWatch News Department was not involved in the creation of this content. -- Clinical data from two ongoing trials in patients undergoing lumpectomy confirm strong safety profile and growing ...